Healthpeak (DOC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.08
- EPS estimate
- $0.03
- EPS surprise
- +184.70%
- Revenue surprise
- +3.33%
- Revenue
- $749.8M
- Revenue estimate
- $725.6M
- Reported
- Aug 4, 2026
Healthpeak reported Q2 2026 results on August 4, 2026. Earnings per share came in at $0.08, ahead of the $0.03 estimate by 184.70%. Revenue was $749.8 million, above the $725.6 million consensus by about 3.3%. Compared with Q2 2025, EPS rose from $0.05 and revenue rose about 10.5% from $678.5 million. Q2 2026 revenue is the highest in the table.
Earnings per share are small and uneven, so percentage surprises tend to look large. Annual EPS fell from $0.92 in 2022 to $0.56 in 2023, $0.35 in 2024 and $0.10 in 2025. The 2025 total includes a loss of $0.17 per share in Q3 2025, the only loss in the table. The first two quarters of 2026 add up to $0.36, compared with $0.11 a year earlier. Revenue has grown more steadily, from $2.06 billion in 2022 to $2.78 billion in 2025, about 35% higher. Over the last 20 quarters, Healthpeak beat EPS estimates 13 times.
Healthpeak reported Q3 between October 23 and November 2 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether revenue holds near the latest level.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.03 | $0.08 | +184.70% | $749.8M | SEC |
| Q1 2026 | May 5, 2026 | $0.05 | $0.28 | +430.30% | $738.8M | SEC |
| Q4 2025 | Feb 2, 2026 | $0.07 | $0.16 | +128.57% | $704.8M | SEC |
| Q3 2025 | Oct 23, 2025 | $0.06 | −$0.17 | −389.12% | $690.3M | SEC |
| Q2 2025 | Jul 24, 2025 | $0.06 | $0.05 | −21.88% | $678.5M | SEC |
| Q1 2025 | Apr 24, 2025 | $0.05 | $0.06 | +10.70% | $702.9M | SEC |
| Q4 2024 | Feb 3, 2025 | $0.05 | $0.01 | −79.12% | $698.0M | SEC |
| Q3 2024 | Oct 24, 2024 | $0.07 | $0.12 | +69.01% | $700.4M | SEC |
| Q2 2024 | Jul 25, 2024 | $0.10 | $0.21 | +109.79% | $695.5M | SEC |
| Q1 2024 | Apr 25, 2024 | $0.02 | $0.01 | −55.75% | $606.6M | SEC |
| Q4 2023 | Feb 8, 2024 | $0.10 | $0.13 | +25.24% | $553.7M | SEC |
| Q3 2023 | Oct 30, 2023 | $0.08 | $0.12 | +45.28% | $556.2M | SEC |
| Q2 2023 | Jul 27, 2023 | $0.11 | $0.09 | −16.51% | $545.4M | SEC |
| Q1 2023 | Apr 27, 2023 | $0.08 | $0.22 | +161.90% | $525.7M | SEC |
| Q4 2022 | Feb 7, 2023 | $0.10 | $0.01 | −90.38% | $524.5M | SEC |
| Q3 2022 | Nov 1, 2022 | $0.09 | $0.65 | +586.38% | $520.4M | SEC |
| Q2 2022 | Aug 2, 2022 | $0.10 | $0.13 | +24.88% | $517.9M | SEC |
| Q1 2022 | May 3, 2022 | $0.09 | $0.13 | +45.09% | $498.4M | SEC |
| Q4 2021 | Feb 8, 2022 | $0.09 | $0.05 | −42.46% | $483.2M | SEC |
| Q3 2021 | Nov 2, 2021 | $0.10 | $0.10 | +4.60% | $481.5M | SEC |
Quarterly revenue
Frequently asked questions
When did Healthpeak (DOC) last report earnings?
Healthpeak last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did DOC beat earnings estimates?
Yes. Healthpeak reported EPS of $0.08 for Q2 2026 against a $0.03 estimate — a 184.70% beat.
How much revenue did DOC report last quarter?
Healthpeak reported $749.8M in revenue for Q2 2026, against a consensus estimate of $725.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.